GaviRaft Oral Suspension is a combination antacid formulation containing Calcium Carbonate (80mg), Sodium Alginate (250mg), and Sodium Bicarbonate (133.5mg) designed for the symptomatic relief of gastroesophageal reflux disease (GERD), heartburn, and acid indigestion. Calcium Carbonate acts as a potent antacid by neutralizing gastric acid, thereby increasing gastric pH and providing rapid relief from acidity-related discomfort. Sodium Alginate forms a viscous gel when it comes into contact with gastric acid, creating a physical barrier or “raft” that floats on the stomach contents, preventing reflux of acid into the esophagus. Sodium Bicarbonate contributes to acid neutralization and enhances the buffering capacity of the suspension, providing immediate symptomatic relief. This combination offers both quick onset of action and prolonged protection against acid reflux. GaviRaft Oral Suspension is indicated for adults and children over 12 years of age experiencing episodic heartburn and acid reflux symptoms. It should be used as directed by a healthcare professional, with caution advised in patients with renal impairment or those on sodium-restricted diets due to the sodium content. Adverse effects are rare but may include mild gastrointestinal disturbances. This formulation provides an effective, well-tolerated option for managing acid-related gastrointestinal conditions.